UroNav Fusion Biopsy System

What Is a Targeted Prostate Biopsy?

A targeted prostate biopsy, often performed using the UroNav Fusion Biopsy system, is an advanced method used to diagnose prostate cancer. This technique combines magnetic resonance imaging (MRI) with real-time ultrasound to create a detailed, three-dimensional view of the prostate. By integrating these technologies, physicians can more accurately locate and biopsy suspicious areas identified on MRI scans.

During a UroNav Fusion Biopsy, the patient first undergoes an MRI scan that produces high-resolution images of the prostate. These images help identify areas that may appear abnormal or concerning. The MRI images are then combined with real-time ultrasound during the biopsy procedure. This fusion of imaging allows the physician to guide the biopsy needle directly to the targeted areas rather than relying on traditional random sampling.

Because the biopsy focuses on specific regions of concern, this approach can improve the accuracy of prostate cancer detection.

Why Would a Patient Need a UroNav Fusion Biopsy?

A targeted biopsy may be recommended in several situations. One common reason is an elevated prostate-specific antigen (PSA) level, which can indicate the possibility of prostate cancer.

This procedure may also be recommended if a patient has previously had a negative or inconclusive biopsy but continues to have elevated PSA levels or abnormal findings during a digital rectal exam. In these cases, a targeted biopsy can help identify cancer that may have been missed during earlier testing.

Additionally, men who have already been diagnosed with low-risk prostate cancer and are undergoing active surveillance may have a targeted biopsy to monitor for any changes or progression of the disease.

Benefits of a Targeted Prostate Biopsy

Targeted biopsy techniques provide several advantages compared with traditional biopsy methods:

• Improved ability to detect aggressive prostate tumors

• Greater precision by focusing on suspicious areas identified on MRI

• Reduced likelihood of missing clinically significant cancers

• More accurate diagnosis to guide appropriate treatment decisions

By providing more detailed information about the presence and location of cancer, targeted prostate biopsy can help physicians develop more effective and personalized treatment plans.

If your physician has recommended a prostate biopsy, consider discussing whether a targeted biopsy using the UroNav Fusion system may be appropriate for your situation.